Hypertension Drugs Market Size & Share, by Drug Class (Alpha & Beta Blockers, Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, Renin Inhibitors); Type (Systemic, Pulmonary); Distribution Channel (Hospitals, Clinics, Research Laboratories, Retail Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 2845
  • Published Date: Jul 27, 2023
  • Report Format: PDF, PPT

Companies Dominating the Hypertension Drugs Landscape

top-features-companies
    • Janssen Global Services, LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Atnahs Pharma UK Limited
    • Sanofi US Services Inc.
    • Pfizer Laboratories Div Pfizer Inc
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Daiichi Sankyo Company, Limited
    • Novartis Pharmaceuticals Corporation
    • Boehringer Ingelheim group
    • Lupin Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Janssen Global Services, LLC announced that it has submitted an approval request to the U.S. Food and Drug Administration (FDA) for OPSUMIT (macitentan) for treating adults with inoperable chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4)
  • AstraZeneca announced that it has completed the divestment agreement of its established hypertension medicines with Atnahs Pharma UK Limited.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 2845
  • Published Date: Jul 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of hypertension around the world and the growing prevalence of insomnia across the globe are the major factors driving the growth of the market.

The market size of Hypertension Drugs is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2035.

The major players in the market are Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, and others.

The diuretics segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying